EGFR and epithelioid sarcoma: Similar to epithelioid sarcoma, EGFR overexpression is present in certain epithelial cancers but overexpression alone does not predict treatment response to EGFR inhibition, in contrast to kinase domain mutations, e.g. in exons 18–21 of EGFR in NSCLC patients [23, 36, 37].